• Latest Posts
Sponsored by 17 Oct 2023

Can we overcome the challenges of bispecific antibody production?

New drug helps prostate cancer patients

ADVERTISEMENT

Swiss researchers develop new class of antibiotics to fight resistant bacteria

Lonza boosts ADC portfolio with Synaffix acquisition

Molecular Partners presenting positive solid tumor data

Ironwood acquires VectivBio in $1B deal

Diagnosing inflammatory diseases with synthetic peptides

Cell and gene therapy company NewBiologix exits stealth with $50M

ADVERTISEMENT